Table 2 Reduction in OSDI and SPEEDII scores (post vs. pre-injection) with comparison between cohorts
Variable name | Description | All | 15ML | 10ML | 3ML (n = 51) | p-value |
|---|---|---|---|---|---|---|
(n = 142) | (n = 46) | (n = 45) | ||||
REDUCTION IN OSDI | mean and | 8.3 | 13.1 | 4.8 | 7.3 | 0.0690 |
std | -17.5 | -17.1 | -15 | -19.4 | ||
median and | 7.6 | 9 | 4.2 | 8.7 | ||
IQR | (0.0, 16.7) | (2.3, 22.7) | (-2.3, 12.1) | (0.0, 15.9) | ||
min and max | (-65.3, 56.9) | (-17.5, 56.9) | (-43.3, 36.4) | (-65.3, 50.8) | ||
(%) missing | 1 (0.7%) | 1 (2.2%) | ||||
REDUCTION IN SPEED II | mean and | 2 | 2.5 | 1.4 | 1.9 | 0.6227 |
std | -5.5 | -5.1 | -6.2 | -5.2 | ||
median and | 2 | 1 | 1 | 2 | ||
IQR | (-1.0, 5.0) | (0.0, 6.0) | (-1.0, 3.0) | (-2.0, 4.0) | ||
min and max | (-19.0, 19.0) | (-7.0, 19.0) | (-19.0, 15.0) | (-10.0, 19.0) | ||
(%) missing | 1 (0.7%) | 1 (2.2%) |